The MedTech Accelerator supports Imperial researchers to develop and translate medical technologies with strong clinical and commercial potential, guiding projects from early research through to clinical validation and real-world adoption.
We support translational MedTech projects by providing:
-
Translational project management aligned to Technology Readiness Levels (TRLs)
-
Quality Assurance and Regulatory Affairs (QARA) support, including regulatory strategy and quality systems
-
Strategic guidance on clinical and commercial development pathways
-
Access to Imperial’s clinical collaborators and NHS partners
-
Support to secure follow-on funding, licensing, or spin-out opportunities
Successful translation requires more than strong science. Projects must address a clear clinical need, demonstrate a credible route to market, and follow a realistic regulatory pathway. The MedTech Accelerator helps teams navigate these challenges and progress technologies toward clinical use and patient impact.
